NCT07564908Active, not recruiting
Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases
Source: ClinicalTrials.gov · Last updated 4 May 2026
Brief summary (registry, in English)
Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 64 (estimated)
- First submitted
- 27 Apr 2026
- Start date
- 1 Jan 2018
- Primary completion date
- 30 Dec 2030
- Lead sponsor
- Meng Qiu
- Diseases
- Colorectal cancer, Childhood cancers
- NCT number
- NCT07564908
What you commit to
- Study type: Observational
- Planned participants: 64
- From 1 Jan 2018 to the primary completion date, 30 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients did not undergo R0 resection
Other
- Postoperative specimens were unavailable
- Clinical data were incomplete.
Who the study is looking for
- Patients with CRLM who underwent R0 resection
- Histologically or cytologically confirmed CRLM
- Have sufficient liver metastasis tissue specimens available for analysis
- Complete treatment and follow-up records
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| West China Hospital of Sichuan University Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.